Back to Results
First PageMeta Content
Pharmaceutical Benefits Scheme / Pharmaceuticals policy / Quality use of medicines / Osteoporosis / Antidepressant / Antipsychotic / Attention deficit hyperactivity disorder / Smoking cessation / Health / Medicine / Healthcare in Australia


Drug Utilisation Sub-Committee Outcome Statement 4-5 October 2012
Add to Reading List

Document Date: 2015-03-20 01:07:13


Open Document

File Size: 83,00 KB

Share Result on Facebook

Country

Australia / /

/

IndustryTerm

media campaigns / treatment of HIV / fixed dose combination products / telephone authority approval / management tool / /

MedicalCondition

HIV infection / ADHD / intrinsic renal disease / HIV / diabetes / severe acne vulgaris / Attention Deficit Hyperactivity Disorder / severe allergic asthma / multiple sclerosis / Diabetes DUSC / osteoporosis / Multiple Sclerosis A / complex refractory fistulising Crohn disease / depression / Osteoporosis DUSC / /

MedicalTreatment

Nicotine Replacement Therapy / oral therapies / /

Organization

DUSC Secretariat / National Prescribing Service / Pharmaceutical Benefits Advisory Committee / National Park Service / National Science Foundation / PBAC DUSC / Territory Health Department / /

Person

David Le Couteur / /

Position

Governor / Professor / Chair / /

Product

Testosterone / PBS prescriptions / Nicotine / /

URL

http /

SocialTag